Here, we showed that one mutation (A > T) at 3′ UTR of BCL9L could influence the luciferase reporter activity in BC cells, suggesting that this mutation might be responsible for an aberrant expression of BCL9L. This evidence concerns the gene BCL9L and breast cancer.